<DOC>
	<DOCNO>NCT02705768</DOCNO>
	<brief_summary>The present study plan assess level serum neuron-specific enolase ( NSE ) focal seizure change antiepileptic therapy .</brief_summary>
	<brief_title>Effect Carbamazepine Oxcarbazepine Serum Neuron-specific Enolase Focal Seizures</brief_title>
	<detailed_description>Epileptic seizure cause neuronal cell death , enhance neurogenesis , axonal sprouting , dendritic change , reactive gliosis . Histopathological analysis suggest initial insult recurrent seizures contribute neuronal damage . Activation mesial temporal structure likely cause damage area brain ; therefore , one consequence prolong seizure selective neuronal loss hippocampus . The excitotoxic damage consider important mechanism injury also evidence program cell death contribute neuronal damage . Various biomarkers brain damage study context epilepsy brain damage widely investigated biochemical biomarker neuron-specific enolase ( NSE ) . NSE γγ-isoenzyme enolase involve glycolysis pathway . NSE originate predominantly cytoplasm neuron neuroendocrine cell . Neuronal damage impairment blood brain barrier integrity detect release NSE cerebrospinal fluid ( CSF ) eventually blood . NSE therefore regard marker neuronal damage prognosis various disorder associate cell damage central peripheral nervous system . CSF serum NSE level obtain within first 48 hour find elevate correlate well duration epilepsy outcome patient . Some study show elevated NSE level temporal lobe epilepsy , single tonic-clonic seizure , status epilepticus . Literature review reveals lack data serum NSE focal seizure study effect antiepileptic drug level serum NSE . So present study plan assess level serum NSE focal seizure change antiepileptic therapy .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>All patient clinical diagnosis localization relate epilepsy/focal seizure ( International League Against Epilepsy 2010 ) history episode seizure within 48 hour presentation Treatment naïve patient patient take treatment least 3 week inclusion . History recent traumatic brain injury , cerebral ischemia/transient ischemic attack/stroke Patients neuroendocrinal tumour History invasive neurosurgical /noninvasive neuropsychiatric procedure . Patients already treatment present condition . Medication history psychoactive central nervous system depressant drug Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Neuron-specific enolase ( NSE )</keyword>
	<keyword>Carbamazepine</keyword>
	<keyword>Oxcarbazepine</keyword>
</DOC>